Wave 3 Research Reactivation Announced

June 15, 2020

A message from Dr. Kunkel

Dear Colleagues,

We’ve reached an important milestone for the ramp-up of bench laboratory research at the Medical School – on Thursday, June 18, the last buildings awaiting reactivation will reopen. Please remember that all dry research/office work will continue to remain remote at this time. Buildings reopening in this wave:

  • Med Sci I
  • Med Sci II
  • Rogel Cancer Center
  • Brehm
  • Kellogg
  • NCRC 20
  • NCRC 26
  • NCRC 520
  • ARF
  • Buhl
  • NIB

Additionally, assuming all continues to go well in the buildings currently reactivated, the following additional shifts will be added:

  • Thursday, June 18 – BSRB will add increased flexibility to their shifts, thus returning remaining team members.
  • Monday, June 22 - a second shift will be added to Wave 2 buildings.

We have communicated the reactivation process for these buildings to department leadership. As with the buildings in the first two waves, wet labs in these buildings will reopen in compliance with the guidelines from both the governor and central campus, with an initial 30% of personnel capacity allowed access. Our ability to move into this third wave of reactivation is a credit to the researchers who have worked compliantly and safely in the previous waves, and I’d like to stress that it’s extremely important for returning personnel to adhere to the guidelines. Please remember to wear masks, answer the screening questions, practice safe social distancing, adhere to the times allowed for entry into your building, and maintain your lab cleaning logs. We must continue to work together, so our ability to continue to return personnel to the labs is not jeopardized.

Regarding human subjects research, we continue to work closely with UMOR and the rest of campus to restart that important work and hope to announce a reactivation timeline and process shortly. As we progress further into the summer, I’m confident that the smooth path of these waves of research reactivation bodes well for our future. Thank you for your flexibility, conscientiousness, and patience.

Best regards,
Steve

Steven L. Kunkel, Ph.D.
Executive Vice Dean for Research, Medical School 
Chief Scientific Officer, Michigan Medicine
Peter A. Ward Distinguished University Professor
Endowed Professor of Pathology Research